Global Isoflavone Supplements Market - 2023-2030

Overview

Global Isoflavone Supplements Market reached US$ 721.2 million in 2022 and is expected to reach US$ 1.073.6 million by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

With a growing emphasis on natural and plant-based products, consumers are seeking alternatives to synthetic supplements. Isoflavones, which are naturally occurring compounds found in soybeans and other legumes, fit into this trend, leading to increased demand for isoflavone supplements. Consumers are becoming increasingly aware of the potential health benefits associated with isoflavones, particularly in managing menopausal symptoms, promoting heart health, and potentially reducing the risk of certain cancers.

In April 2021, Pulmuone, a South Korean company, launched a soybean and hop extract supplement for alleviating menopausal symptoms. The company clarified that isoflavones derived from hop extracts and black soybeans were beneficial because they had a chemical structure with the female hormone estrogen, whose production declines during menopause and causes menopausal symptoms.

The soy-based isoflavone supplements account for over half of the market share due to their rich content of naturally occurring isoflavones, such as genistein and daidzein. Similarly, North America dominates the isoflavone supplements market, capturing the largest market share due to a combination of high consumer awareness, robust research infrastructure, and a growing interest in natural health solutions.

Dynamics

Rising Prevalence of Menopausal Symptoms

As the global population ages, there is a growing number of women entering menopause. According to the National Library of Medicine, it is predicted that by 2030, there will be 1.2 billion menopausal and postmenopausal women worldwide, with 47 million of them joining the population annually. With a larger population of women experiencing menopause, there is a greater demand for products that can help manage associated symptoms.

Isoflavones, plant-derived compounds found in soy and other legumes, mimic the effects of estrogen in the body and have been associated with alleviating these symptoms. As awareness of the potential benefits of isoflavone supplements in managing menopausal symptoms grows, so does demand for such products. Additionally, with an increasing aging population worldwide, the number of women experiencing menopause is on the rise, further propelling the market expansion.

Growing Awareness about Health Benefits

Isoflavones are naturally occurring compounds found predominantly in soybeans and other legumes. According to the National Library of Medicine, Cancellieri et found that Based on the Kupperman Menopause Index, hot flashes were dramatically reduced after six months of consuming a herbal supplement comprising 72 mg of isoflavones from red clover and soybeans. Along with menopausal symptom relief, isoflavones have a protective effect on bone health, particularly in postmenopausal women who are at increased risk of osteoporosis.

Isoflavones help maintain bone density and reduce the risk of fractures by modulating bone metabolism and promoting bone formation. Also, isoflavones have been studied for their potential cardiovascular benefits, including their ability to improve lipid profiles by reducing LDL cholesterol levels and increasing HDL cholesterol levels. As consumers become aware of the potential benefits of isoflavone supplements, there is a corresponding increase in demand for these products.

Regulatory Challenges

Regulatory agencies may impose restrictions or guidelines on the marketing and labeling of isoflavone supplements, particularly regarding health claims and safety concerns. Compliance with these regulations can increase costs and limit the ability of manufacturers to promote their products, potentially hindering market expansion in the forecast period.

In January 2020, to comply with notification regulations for dietary supplements and infant formulas, Poland's Chief Sanitary Inspectorate announced to implementation a notification system aimed at "improving supervision" of firms. At the beginning of 2019, Poland started imposing maximum amounts on substances found in food supplements. There, authorities established usage guidelines and limitations for isoflavones (soy and other), aloe vera, and beta-alanine preparations.

Segment Analysis

The global isoflavone supplements market is segmented based on source, application, distribution channel and region.

Abundance of Isoflavones in Soybeans

Soybeans are a rich source of isoflavones, a type of phytoestrogen. For instance, about 3.5 mg of isoflavones are linked to every gram of soy protein found in soybeans and conventional soy foods. As a result, roughly 25 mg of isoflavones are present in one serving of classic soy food, such as 100 g of tofu or 250 mL of soymilk. These compounds are known for potential health benefits, including reducing the risk of certain chronic diseases such as heart disease and osteoporosis and alleviating menopausal symptoms. Due to this natural abundance, soy has become a primary ingredient in many isoflavone supplements.

In October 2023, Pharmalinea introduced an advanced whole-body menopause supplement. According to Maja Oresnik, Science & Research Director, the new supplement contains Soy isoflavones (Qsoy), resveratrol (Qratrol), and vitamin B6, which has been clinically demonstrated to affect phytoestrogen activity, improve cerebral blood flow and vasodilation, enhance insulin sensitivity and cognitive function, slow down the loss of bone mineral density, and lessen chronic pain.

Geographical Penetration

Growing Awareness about Isoflavone Supplements in North America

There is a growing awareness and interest among consumers in North America regarding the health benefits of isoflavones, particularly in managing conditions such as menopausal symptoms and promoting heart health. According to the National Library of Medicine, every year, about 1.3 million women in the US experience menopause. Isoflavone supplements are often utilized to alleviate menopausal symptoms, providing relief to women experiencing discomfort during this transitional phase of life.

Additionally, North America boasts a well-established dietary supplement industry supported by robust distribution channels and widespread availability of various health products, including isoflavone supplements. The accessibility of these supplements through pharmacies, health food stores, online retailers, and other outlets further contributes to the market's dominance in the region.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for isoflavone supplements. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of isoflavone supplements in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for isoflavone supplements, particularly those marketed for their potential health benefits.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine disrupted global supply chains, affecting the transportation of goods and raw materials. Ukraine is a significant producer of soybeans, a primary source of isoflavones used in supplements. The disruptions in soybean production and export from Ukraine led to shortages or delays in the availability of raw materials for isoflavone supplements, thereby affecting the supply chain and potentially leading to price fluctuations in the market.

By Source

• Soy
• Chickpea
• Red Clover
• Others

By Application

• Food & Beverage
• Cosmetics
• Nutraceuticals
• Pharmaceuticals
• Others

By Distribution Channel

• Hypermarkets/Supermarkets
• Drug Stores & Pharmacies
• E-Commerce
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In October 2023, Nutravita, a supplement company, released a new line to help women through the menopausal phase of life with a choice of supplements that successfully address the most prevalent symptoms in honor of 'Menopause Awareness Month'. It contains soy isoflavones, which are phytoestrogen chemicals and a natural substitute for hormone replacement treatment, in addition to essential minerals that support menopause.
• In February 2023, Pro360, the nutraceutical brand of GMN Group of Companies, launched the FemCare+ and HPHF (High Protein High Fibre) product lines. These products are designed to provide both men and women with a variety of advantages to enhance their lifestyles. Among the enriched, natural ingredients used in the FemCare+ collection are Shatavari, Myo-Inositol, Black Cohosh, Evening Primrose, and Soy Isoflavones.
• In November 2021, Otsuka Pharmaceutical Co., Ltd., launched tocoelle, a supplement to support women bothered by pre-menstrual fluctuations. It provides four essential elements: calcium, which is frequently deficient in daily diets; equol, which is made from soy isoflavones; and vitamin E (Y-tocopherol and Y-tocotrienol), which is found in soy oil.
• In March 2023, Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced the launch of launch of a new version of EQUELLE gelee, an extension of the EQUELLE brand of supplements promoting women's health and beauty. It has 3.2 mg of soy isoflavones (aglycone), 2,500 mg of collagen peptides, and 5 mg of S-equol.

Competitive Landscape

The major global players in the market include NOW Health Group, Inc., Solgar Inc., Swanson, Life Extension, GNC Holdings, LLC, Pure Encapsulations, Bluebonnet Nutrition, Douglas Laboratories, Jabs Biotech Pvt. Ltd., 21ST Century HealthCare, Inc.

Why Purchase the Report?

• To visualize the global isoflavone supplements market segmentation based on source, application, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of isoflavone supplements at the market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global isoflavone supplements market report would provide approximately 62 tables, 56 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies